Abstract
A series of complexes PtAm2L [where Am2 = (NH3)2, ethylenediamine(en), 1,2-diaminocyclohexane (DACH) or (NH3)(c-C6H11NH2) and where L is a bidentate 1,1-dicarboxylate ligand tethered to 1- aminoanthraquinone by various spacers] was prepared and screened in vitro against P388 leukemia cells. The free ligands displayed moderate activity and the corresponding platinum complexes were tenfold more active. The nature of the linker chain does not seem to affect the potency of the complexes. The potency depends on the nature of the inert amine ligand [NH3 > DACH > en]. The low aqueous solubility of these complexes prevented any in vivo studies and the preparation of water soluble analogs is currently under way.
| Original language | English |
|---|---|
| Pages (from-to) | 823-831 |
| Number of pages | 9 |
| Journal | European Journal of Medicinal Chemistry |
| Volume | 32 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 1997 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anthraquinone
- Anticancer
- Carrier
- Intercalator
- Platinum
Fingerprint
Dive into the research topics of 'Anthraquinone intercalators as carrier molecules for second-generation platinum anticancer drugs'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver